Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older
PHASE1
The purpose of this phase 1/2 study is to investigate the safety and immuno...
Status
Active Not Recruiting
Location
Velocity Clinical Research - San Diego- Site Number : 8400013
COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older
PHASE3
The most recently discovered coronavirus (SARS-CoV-2) may cause illness in ...